A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-associated Steatohepatitis (MASH)
Interventions
DRUG

Miricorilant (Cohort A)

Miricorilant 100 mg for oral dosing

DRUG

Placebo (Cohort A)

Matching placebo for oral dosing for 48 Weeks

DRUG

Miricorilant (Cohort B)

Miricorilant 100 mg for oral dosing Miricorilant 200 mg for oral dosing

DRUG

Placebo (Cohort B)

Matching placebo for oral dosing for 24 Weeks

Trial Locations (77)

10033

Site #454, New York

13057

Site #445, East Syracuse

20110

Site #463, Manassas

20854

Site #440, Rockville

29557

Site #464, Morehead City

32610

Site # 101, Gainesville

32940

Site #460, Viera

33009

Site #465, Hallandale

33016

Site #430, Hialeah Gardens

Site #438, Miami Lakes

33434

Site #452, Boca Raton

33777

Site #475, Largo

38018

Site #458, Lakewood Rch

Site #461, Cordova

43234

Site #470, Columbus

44145

Site #437, Westlake

45145

Site #448, Dayton

45440

Site #447, Beavercreek

55114

Site #442, Saint Paul

64131

Site #228, Kansas City

70006

Site #061, Metairie

70072

Site #451, Marrero

70363

Site #453, Houma

75230

Site #370, Dallas

76012

Site # 546, Arlington

77030

Site # 066, Houston

77079

Site #305, Houston

77494

Site #459, Katy

78125

Site #433, San Antonio

Site #434, Waco

78229

Site #212, San Antonio

78520

Site #432, Brownsville

78539

Site #213, Edinburg

Site #215, Edinburg

78626

Site #431, Georgetown

78756

Site #545, Austin

78757

Site #211, Austin

84088

Site #441, West Jordan

85224

Site #207, Chandler

85712

Site #209, Tucson

90056

Site #373, Los Angeles

90255

Site #378, Huntington Park

90815

Site #469, Long Beach

91402

Site #214, Panorama City

92704

Site #233, Santa Ana

93534

Site #439, Lancaster

98105

Site #226, Seattle

110029

Site #482, New Delhi

110060

Site #510, New Delhi

110070

Site #501, New Delhi

124001

Site # 494, Rohtak

141002

Site #495, Ludhiana

221005

Site #488, Varanasi

Site #503, Varanasi

226003

Site #549, Lucknow

248001

Site #504, Dehradun

302001

Site #489, Jaipur

302004

Site # 485, Jaipur

360001

Site #513, Rajkot

380053

Site #492, Ahmedabad

390007

Site #502, Vadodara

395009

Site #490, Surat

Site #514, Surat

400008

Site #512, Mumbai

400062

Site #509, Mumbai

412201

Site #496, Pune

440009

Site #500, Nagpur

500003

Site #486, Hyderabad

570015

Site #511, Mysore

625020

Site #508, Madurai

695011

Site #507, Thiruvananthapuram

700020

Site #487, Kolkata

700073

Site #493, Kolkata

700150

Site #491, Kolkata

781032

Site #506, Guwahati

08724

Site #455, Jackson

00927-4807

Site #457, San Juan

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY